The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASTRO 2022 | Challenges and unmet needs of treating patients with hepatocellular carcinoma with radiotherapy
Alejandra Mendez Romero, MD, PhD, Erasmus MC Cancer Institute, Rotterdam, Netherlands, discusses the difficulties of finding the balance between killing a liver cancer tumor and preserving liver function, when treating patients with hepatocellular carcinoma with radiotherapy. Dr Romero also emphasises the need for more data to support future guidelines in this field, along with the importance of improving worldwide access to radiotherapy. This interview took place at the American Society for Radiation Oncology (ASTRO) 2022 Congress in San Antonio, Tx.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
